LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5683 | 5505 | 1.0323 | 1.0463 |
BT-20 | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1657 | 3629 | 5505 | 0.6591 | 0.5123 |
BT-20 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 4847 | 5505 | 0.8804 | 0.8288 |
BT-20 | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5441 | 5505 | 0.9883 | 0.9832 |
BT-20 | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5280 | 5505 | 0.9590 | 0.9414 |
BT-20 | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5559 | 5505 | 1.0097 | 1.0139 |
BT-20 | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1781 | 5505 | 0.3236 | 0.0321 |
BT-20 | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1551 | 5505 | 0.2818 | -0.0276 |
BT-20 | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1709 | 5505 | 0.3104 | 0.0133 |
BT-20 | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 4368 | 5505 | 0.7934 | 0.7043 |
BT-20 | TWS119 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5466 | 5505 | 0.9929 | 0.9899 |
BT-20 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5543 | 5505 | 1.0069 | 1.0099 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 1657 | 4776 | 5505 | 0.8675 | 0.8104 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 1657 | 4431 | 5505 | 0.8049 | 0.7209 |
BT-20 | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 2430 | 5505 | 0.4415 | 0.2009 |
BT-20 | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1863 | 5505 | 0.3385 | 0.0535 |
BT-20 | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 4487 | 5505 | 0.8150 | 0.7353 |
BT-20 | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 4915 | 5505 | 0.8928 | 0.8467 |
BT-20 | YM 201636 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5135 | 5505 | 0.9327 | 0.9037 |
BT-20 | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 3379 | 5505 | 0.6139 | 0.4475 |
BT-20 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 5087 | 5505 | 0.9241 | 0.8914 |
BT-20 | Sigma A6730 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4941 | 5505 | 0.8974 | 0.8533 |
BT-20 | Alvocidib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1130 | 5505 | 0.2053 | -0.1371 |
BT-20 | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1474 | 5505 | 0.2677 | -0.0478 |
BT-20 | AZD 5438 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1829 | 5505 | 0.3323 | 0.0447 |